CM
WST icon

Castleark Management’s West Pharmaceutical WST Stock Holding History

Castleark Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,105
Closed -$2.46M – 408
2018
Q4 		$2.46M Sell
25,105
-18,650
-43% -$2.02M 0.1% 203
2018
Q3 		$5.4M Buy
+43,755
New +$4.91M 0.16% 189
2017
Q4 		– Sell
-34,985
Closed -$3.37M – 445
2017
Q3 		$3.37M Buy
+34,985
New +$3.17M 0.11% 222
2016
Q4 		– Sell
-149,985
Closed -$11.2M – 424
2016
Q3 		$11.2M Sell
149,985
-9,110
-6% -$723K 0.34% 82
2016
Q2 		$12.1M Sell
159,095
-29,005
-15% -$2.11M 0.39% 71
2016
Q1 		$13M Buy
+188,100
New +$11.3M 0.41% 62

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return